pantoprazole has been researched along with Myocardial Ischemia in 2 studies
Pantoprazole: 2-pyridinylmethylsulfinylbenzimidazole proton pump inhibitor that is used in the treatment of GASTROESOPHAGEAL REFLUX and PEPTIC ULCER.
pantoprazole : A member of the class of benzimidazoles that is 1H-benzimidazole substituted by a difluoromethoxy group at position 5 and a [(3,4-dimethoxypyridin-2-yl)methyl]sulfinyl group at position 2.
Myocardial Ischemia: A disorder of cardiac function caused by insufficient blood flow to the muscle tissue of the heart. The decreased blood flow may be due to narrowing of the coronary arteries (CORONARY ARTERY DISEASE), to obstruction by a thrombus (CORONARY THROMBOSIS), or less commonly, to diffuse narrowing of arterioles and other small vessels within the heart. Severe interruption of the blood supply to the myocardial tissue may result in necrosis of cardiac muscle (MYOCARDIAL INFARCTION).
| Excerpt | Relevance | Reference |
|---|---|---|
| " In the present study, the effect of PPI pantoprazole on ventricular arrhythmias induced by either ischemia or ischemia-reperfusion (I/R) was studied." | 7.81 | Chronic pantoprazole administration and ischemia--reperfusion arrhythmias in vivo in rats--antiarrhythmic or arrhythmogenic? ( Abdel-Kawy, HS, 2015) |
| "Pantoprazole was administered via jugular vein at the dose of 9 mg/kg starting from 30 minutes before ischemia, to the first 30 minutes of reperfusion." | 5.39 | Does pantoprazole protect against reperfusion injury following myocardial ischemia in rats? ( Akdemir, OC; Bacaksiz, A; Buyukpinarbasili, N; Erdogan, E; Ertas, G; Inan, O; Sonmez, O; Tasal, A; Teker, ME; Turfan, M, 2013) |
| " In the present study, the effect of PPI pantoprazole on ventricular arrhythmias induced by either ischemia or ischemia-reperfusion (I/R) was studied." | 3.81 | Chronic pantoprazole administration and ischemia--reperfusion arrhythmias in vivo in rats--antiarrhythmic or arrhythmogenic? ( Abdel-Kawy, HS, 2015) |
| "Pantoprazole was administered via jugular vein at the dose of 9 mg/kg starting from 30 minutes before ischemia, to the first 30 minutes of reperfusion." | 1.39 | Does pantoprazole protect against reperfusion injury following myocardial ischemia in rats? ( Akdemir, OC; Bacaksiz, A; Buyukpinarbasili, N; Erdogan, E; Ertas, G; Inan, O; Sonmez, O; Tasal, A; Teker, ME; Turfan, M, 2013) |
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 0 (0.00) | 18.7374 |
| 1990's | 0 (0.00) | 18.2507 |
| 2000's | 0 (0.00) | 29.6817 |
| 2010's | 2 (100.00) | 24.3611 |
| 2020's | 0 (0.00) | 2.80 |
| Authors | Studies |
|---|---|
| Abdel-Kawy, HS | 1 |
| Bacaksiz, A | 1 |
| Teker, ME | 1 |
| Buyukpinarbasili, N | 1 |
| Inan, O | 1 |
| Tasal, A | 1 |
| Sonmez, O | 1 |
| Erdogan, E | 1 |
| Turfan, M | 1 |
| Akdemir, OC | 1 |
| Ertas, G | 1 |
2 other studies available for pantoprazole and Myocardial Ischemia
| Article | Year |
|---|---|
Chronic pantoprazole administration and ischemia--reperfusion arrhythmias in vivo in rats--antiarrhythmic or arrhythmogenic?
Topics: 2-Pyridinylmethylsulfinylbenzimidazoles; Animals; Anti-Arrhythmia Agents; Arrhythmias, Cardiac; Dise | 2015 |
Does pantoprazole protect against reperfusion injury following myocardial ischemia in rats?
Topics: 2-Pyridinylmethylsulfinylbenzimidazoles; Animals; Blood Pressure; Creatine Kinase, MB Form; H(+)-K(+ | 2013 |